Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment.
- DOI
- 10.1002/cam4.4506
- Published
- 2022 Feb
- Container
- Cancer medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.4506,
title = {Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment.},
author = {Weitzenböck HP and Gschwendtner A and Wiesner C and Depke M and Schmidt F and Trautinger F and Hengstschläger M and Hundsberger H and Mikula M},
year = {2022},
journal = {Cancer medicine},
doi = {10.1002/cam4.4506},
url = {https://doi.org/10.1002/cam4.4506}
}RIS
TY - JOUR TI - Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment. AU - Weitzenböck HP AU - Gschwendtner A AU - Wiesner C AU - Depke M AU - Schmidt F AU - Trautinger F AU - Hengstschläger M AU - Hundsberger H AU - Mikula M PY - 2022 JO - Cancer medicine DO - 10.1002/cam4.4506 UR - https://doi.org/10.1002/cam4.4506 ER -
APA
HP, W., A, G., C, W., M, D., F, S., F, T., M, H., H, H., & M, M. (2022). Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment.. Cancer medicine. https://doi.org/10.1002/cam4.4506
Source records
- pubmed · retrieved 2026-09-25T05:54:02.151Z